These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 26497521

  • 1. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
    Lu J, Sun PD.
    Immunol Rev; 2015 Nov; 268(1):192-200. PubMed ID: 26497521
    [Abstract] [Full Text] [Related]

  • 2. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM, Kiyoshi M, Tsumoto K.
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [Abstract] [Full Text] [Related]

  • 3. Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.
    Lu J, Chu J, Zou Z, Hamacher NB, Rixon MW, Sun PD.
    Proc Natl Acad Sci U S A; 2015 Jan 20; 112(3):833-8. PubMed ID: 25561553
    [Abstract] [Full Text] [Related]

  • 4. The high-affinity receptor for IgG, FcγRI, of humans and non-human primates.
    Chenoweth AM, Trist HM, Tan PS, Wines BD, Hogarth PM.
    Immunol Rev; 2015 Nov 20; 268(1):175-91. PubMed ID: 26497520
    [Abstract] [Full Text] [Related]

  • 5. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
    Dashivets T, Thomann M, Rueger P, Knaupp A, Buchner J, Schlothauer T.
    PLoS One; 2015 Nov 20; 10(12):e0143520. PubMed ID: 26657484
    [Abstract] [Full Text] [Related]

  • 6. Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.
    Ahmed AA, Keremane SR, Vielmetter J, Bjorkman PJ.
    J Struct Biol; 2016 Apr 20; 194(1):78-89. PubMed ID: 26850169
    [Abstract] [Full Text] [Related]

  • 7. A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors.
    Blundell P, Pleass R.
    Methods Mol Biol; 2019 Apr 20; 1904():417-421. PubMed ID: 30539483
    [Abstract] [Full Text] [Related]

  • 8. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O, Gilliland GL, Brezski RJ, Strake B, Wilkinson T, Lacy ER, Scallon B, Teplyakov A, Malia TJ, Strohl WR.
    Methods; 2014 Jan 01; 65(1):114-26. PubMed ID: 23872058
    [Abstract] [Full Text] [Related]

  • 9. Crystal structure of Fcγ receptor I and its implication in high affinity γ-immunoglobulin binding.
    Lu J, Ellsworth JL, Hamacher N, Oak SW, Sun PD.
    J Biol Chem; 2011 Nov 25; 286(47):40608-13. PubMed ID: 21965667
    [Abstract] [Full Text] [Related]

  • 10. CD16a with oligomannose-type N-glycans is the only "low-affinity" Fc γ receptor that binds the IgG crystallizable fragment with high affinity in vitro.
    Subedi GP, Barb AW.
    J Biol Chem; 2018 Oct 26; 293(43):16842-16850. PubMed ID: 30213862
    [Abstract] [Full Text] [Related]

  • 11. The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor.
    Subedi GP, Barb AW.
    MAbs; 2016 Oct 26; 8(8):1512-1524. PubMed ID: 27492264
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
    Sondermann P, Kaiser J, Jacob U.
    J Mol Biol; 2001 Jun 08; 309(3):737-49. PubMed ID: 11397093
    [Abstract] [Full Text] [Related]

  • 13. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa.
    Sakae Y, Satoh T, Yagi H, Yanaka S, Yamaguchi T, Isoda Y, Iida S, Okamoto Y, Kato K.
    Sci Rep; 2017 Oct 23; 7(1):13780. PubMed ID: 29062024
    [Abstract] [Full Text] [Related]

  • 14. Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI binding.
    Ju MS, Na JH, Yu YG, Kim JY, Jeong C, Jung ST.
    Mol Immunol; 2015 Oct 23; 67(2 Pt B):350-6. PubMed ID: 26153451
    [Abstract] [Full Text] [Related]

  • 15. Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan.
    Falconer DJ, Subedi GP, Marcella AM, Barb AW.
    ACS Chem Biol; 2018 Aug 17; 13(8):2179-2189. PubMed ID: 30016589
    [Abstract] [Full Text] [Related]

  • 16. Restricted processing of CD16a/Fc γ receptor IIIa N-glycans from primary human NK cells impacts structure and function.
    Patel KR, Roberts JT, Subedi GP, Barb AW.
    J Biol Chem; 2018 Mar 09; 293(10):3477-3489. PubMed ID: 29330305
    [Abstract] [Full Text] [Related]

  • 17. The many faces of FcγRI: implications for therapeutic antibody function.
    Swisher JF, Feldman GM.
    Immunol Rev; 2015 Nov 09; 268(1):160-74. PubMed ID: 26497519
    [Abstract] [Full Text] [Related]

  • 18. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
    Hayes JM, Frostell A, Cosgrave EF, Struwe WB, Potter O, Davey GP, Karlsson R, Anneren C, Rudd PM.
    J Proteome Res; 2014 Dec 05; 13(12):5471-85. PubMed ID: 25345863
    [Abstract] [Full Text] [Related]

  • 19. Structural insights into the interaction of human IgG1 with FcγRI: no direct role of glycans in binding.
    Oganesyan V, Mazor Y, Yang C, Cook KE, Woods RM, Ferguson A, Bowen MA, Martin T, Zhu J, Wu H, Dall'Acqua WF.
    Acta Crystallogr D Biol Crystallogr; 2015 Nov 05; 71(Pt 11):2354-61. PubMed ID: 26527150
    [Abstract] [Full Text] [Related]

  • 20. Restricted motion of the conserved immunoglobulin G1 N-glycan is essential for efficient FcγRIIIa binding.
    Subedi GP, Hanson QM, Barb AW.
    Structure; 2014 Oct 07; 22(10):1478-88. PubMed ID: 25199692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.